The successful candidate will join the Genomic Medicine Drug Product Development group. This individual will be an integral part of a dynamic and growing group of scientists and engineers developing adeno-associated virus (AAV) based gene therapy products within the larger organization. This team member will execute studies for the development of AAV formulations, fill-finish processes, and clinical device compatibility to ensure clinical and commercial readiness.
You will be responsible for:
- Execution of formulation studies and non-GMP stability studies for AAV-based drug candidates
- Clinical administrative device compatibility and In-use studies for clinical dosing enablement
- Supporting the development of GMP fill finish processes
- Developing presentations for internal presentations
- Technical report authoring and data verification.
You will need to have:
- BS in Pharmaceutics, Biochemistry, Chemical Engineering, or relevant field with 2+ years, a MS with 1+ years of relevant experience
- Hands on experience with biologic drug development
- Understanding of protein chemistry, formulation, and degradation
- Ability to work effectively in a cross-functional settings
- Excellent interpersonal and communication skills
Highly Valued:
- Experience developing stabilizing, clinically acceptable formulations, and fill finish processes for biologics.
- Experience with biopharmaceutical assays (CE, SEC, SVP analysis, DLS, etc.).